DE60334536D1 - Furylverbindungen - Google Patents
FurylverbindungenInfo
- Publication number
- DE60334536D1 DE60334536D1 DE60334536T DE60334536T DE60334536D1 DE 60334536 D1 DE60334536 D1 DE 60334536D1 DE 60334536 T DE60334536 T DE 60334536T DE 60334536 T DE60334536 T DE 60334536T DE 60334536 D1 DE60334536 D1 DE 60334536D1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- furylverbindungen
- compositions
- therapy
- pharmaceutically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201186A SE0201186D0 (sv) | 2002-04-18 | 2002-04-18 | Furyl compounds |
| SE0203607A SE0203607D0 (sv) | 2002-12-04 | 2002-12-04 | Furyl compounds |
| PCT/SE2003/000613 WO2003087102A1 (en) | 2002-04-18 | 2003-04-15 | Furyl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60334536D1 true DE60334536D1 (de) | 2010-11-25 |
Family
ID=29253788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60334536T Expired - Lifetime DE60334536D1 (de) | 2002-04-18 | 2003-04-15 | Furylverbindungen |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7417049B2 (de) |
| EP (1) | EP1499618B1 (de) |
| JP (1) | JP4511195B2 (de) |
| KR (1) | KR20040099447A (de) |
| CN (1) | CN1325500C (de) |
| AT (1) | ATE484508T1 (de) |
| AU (1) | AU2003225456B2 (de) |
| BR (1) | BR0309343A (de) |
| CA (1) | CA2482311C (de) |
| DE (1) | DE60334536D1 (de) |
| IL (1) | IL164509A0 (de) |
| MX (1) | MXPA04010191A (de) |
| NO (1) | NO20044996L (de) |
| NZ (1) | NZ561794A (de) |
| WO (1) | WO2003087102A1 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| ATE551340T1 (de) | 2001-10-02 | 2012-04-15 | Pharmacia & Upjohn Co Llc | Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| WO2003087103A1 (en) * | 2002-04-18 | 2003-10-23 | Astrazeneca Ab | Thienyl compounds |
| MXPA06004299A (es) * | 2003-10-21 | 2006-06-05 | Astrazeneca Ab | Derivados de arilespirofuropiridina. |
| US7045530B2 (en) | 2003-12-22 | 2006-05-16 | Abbott Laboratories | Spirocyclic quinuclidinic ether derivatives |
| TW200813067A (en) * | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
| SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| TWI488854B (zh) | 2008-06-20 | 2015-06-21 | Astrazeneca Ab | 二苯并噻氮呯衍生物及其用途 |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| PE20130218A1 (es) | 2010-05-17 | 2013-03-20 | Envivo Pharmaceuticals Inc | Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidratado |
| BR112012030004A2 (pt) * | 2010-05-27 | 2016-08-02 | Targacept Inc | antagonistas não competitivos de receptor nicotínico |
| GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
| GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
| JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
| EP2846796A4 (de) | 2012-05-08 | 2015-10-21 | Forum Pharmaceuticals Inc | Verfahren zur aufrechterhaltung, behandlung oder verbesserung der kognitiven funktion |
| GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
| WO2014122474A1 (en) | 2013-02-07 | 2014-08-14 | Takeda Pharmaceutical Company Limited | Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists |
| EA029430B1 (ru) | 2013-06-21 | 2018-03-30 | Такеда Фармасьютикл Компани Лимитед | Производные 1-сульфонилпиперидина в качестве модуляторов рецепторов прокинетицина |
| GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
| GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
| GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
| TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
| EP3215512A1 (de) | 2014-11-04 | 2017-09-13 | Bristol-Myers Squibb Company | Chinuclidin-verbindungen als alpha-7-nikotin-acetylcholin-rezpetorliganden |
| GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
| CN108018049B (zh) * | 2016-10-28 | 2019-09-27 | 西安近代化学研究所 | 具有5,6-二氟取代苯并呋喃环的液晶化合物 |
| CN108003895B (zh) * | 2016-10-28 | 2019-04-19 | 西安近代化学研究所 | 一种向列相液晶组合物及其显示元件 |
| GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
| EP3790876B1 (de) | 2018-05-10 | 2025-04-30 | Zoetis Services LLC | Endoparasitische depsipeptide |
| JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
| FR2788982B1 (fr) | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
| IL158735A0 (en) * | 2001-06-01 | 2004-05-12 | Astrazeneca Ab | Novel ligand for nicotinic acetylcholine receptors useful in therapy |
| US6569865B2 (en) | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
| WO2003087103A1 (en) * | 2002-04-18 | 2003-10-23 | Astrazeneca Ab | Thienyl compounds |
-
2003
- 2003-04-15 EP EP03746523A patent/EP1499618B1/de not_active Expired - Lifetime
- 2003-04-15 CN CNB038138956A patent/CN1325500C/zh not_active Expired - Fee Related
- 2003-04-15 NZ NZ561794A patent/NZ561794A/en unknown
- 2003-04-15 CA CA002482311A patent/CA2482311C/en not_active Expired - Fee Related
- 2003-04-15 US US10/511,535 patent/US7417049B2/en not_active Expired - Fee Related
- 2003-04-15 AU AU2003225456A patent/AU2003225456B2/en not_active Ceased
- 2003-04-15 MX MXPA04010191A patent/MXPA04010191A/es active IP Right Grant
- 2003-04-15 BR BR0309343-3A patent/BR0309343A/pt not_active IP Right Cessation
- 2003-04-15 AT AT03746523T patent/ATE484508T1/de not_active IP Right Cessation
- 2003-04-15 JP JP2003584058A patent/JP4511195B2/ja not_active Expired - Fee Related
- 2003-04-15 WO PCT/SE2003/000613 patent/WO2003087102A1/en not_active Ceased
- 2003-04-15 DE DE60334536T patent/DE60334536D1/de not_active Expired - Lifetime
- 2003-04-15 KR KR10-2004-7016547A patent/KR20040099447A/ko not_active Ceased
-
2004
- 2004-10-11 IL IL16450904A patent/IL164509A0/xx unknown
- 2004-11-17 NO NO20044996A patent/NO20044996L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0309343A (pt) | 2005-02-15 |
| CN1325500C (zh) | 2007-07-11 |
| HK1079519A1 (en) | 2006-04-07 |
| WO2003087102A1 (en) | 2003-10-23 |
| NO20044996L (no) | 2005-01-18 |
| NZ561794A (en) | 2008-11-28 |
| US7417049B2 (en) | 2008-08-26 |
| CA2482311C (en) | 2009-12-08 |
| KR20040099447A (ko) | 2004-11-26 |
| EP1499618A1 (de) | 2005-01-26 |
| US20050176745A1 (en) | 2005-08-11 |
| JP2005533012A (ja) | 2005-11-04 |
| JP4511195B2 (ja) | 2010-07-28 |
| MXPA04010191A (es) | 2005-02-03 |
| EP1499618B1 (de) | 2010-10-13 |
| AU2003225456A1 (en) | 2003-10-27 |
| CN1662541A (zh) | 2005-08-31 |
| AU2003225456B2 (en) | 2009-02-05 |
| ATE484508T1 (de) | 2010-10-15 |
| CA2482311A1 (en) | 2003-10-23 |
| IL164509A0 (en) | 2005-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60334536D1 (de) | Furylverbindungen | |
| NO20044995L (no) | Heterosykliske forbindelser | |
| DE60333746D1 (de) | Thienylverbindungen | |
| SE0202463D0 (sv) | Novel compounds | |
| IS7721A (is) | Píperidín-pýrídasón og þalasón sem PDE4 hemlar | |
| SE0401971D0 (sv) | Piperidne derivatives | |
| SE0101387D0 (sv) | Novel compounds | |
| MX2007005933A (es) | Compuestos de acetamida como fungicidas. | |
| SE0401970D0 (sv) | Novel compounds | |
| SE0302139D0 (sv) | Novel compounds | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| SE0302546D0 (sv) | New compounds | |
| SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
| ATE457977T1 (de) | Biguanidderivate | |
| SE0203303D0 (sv) | Novel Compounds | |
| GB0229081D0 (en) | Multifunctional cationic photoinitiators, their preparation and use | |
| SE0300105D0 (sv) | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof | |
| SE0203300D0 (sv) | Novel Compounds | |
| EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
| SE0203302D0 (sv) | Novel Compounds | |
| DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
| NO20030500D0 (no) | Dihydroporfyrinderivater og deres anvendelse | |
| MXPA06004299A (es) | Derivados de arilespirofuropiridina. | |
| DK1638948T3 (da) | Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere | |
| ATE416162T1 (de) | Naphthamidderivate und deren verwendung |